Piwnica-Worms D - Search Results

1

Senescent stromal-derived osteopontin promotes preneoplastic cell growth.

Pazolli E, Luo X, Brehm S, Carbery K, Chung JJ, Prior JL, Doherty J, Demehri S, Salavaggione L, Piwnica-Worms D, Stewart SA. Pazolli E, et al. Cancer Res. 2009 Feb 1;69(3):1230-9. doi: 10.1158/0008-5472.CAN-08-2970. Epub 2009 Jan 20. Cancer Res. 2009. PMID: 19155301 Free PMC article.

2

Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.

Luker KE, Pica CM, Schreiber RD, Piwnica-Worms D. Luker KE, et al. Cancer Res. 2001 Sep 1;61(17):6540-7. Cancer Res. 2001. PMID: 11522652

3

Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate.

Violini S, Sharma V, Prior JL, Dyszlewski M, Piwnica-Worms D. Violini S, et al. Biochemistry. 2002 Oct 22;41(42):12652-61. doi: 10.1021/bi026097e. Biochemistry. 2002. PMID: 12379107

4

Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice.

Luker GD, Bardill JP, Prior JL, Pica CM, Piwnica-Worms D, Leib DA. Luker GD, et al. J Virol. 2002 Dec;76(23):12149-61. doi: 10.1128/jvi.76.23.12149-12161.2002. J Virol. 2002. PMID: 12414955 Free PMC article.

5

Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy.

Bullok KE, Dyszlewski M, Prior JL, Pica CM, Sharma V, Piwnica-Worms D. Bullok KE, et al. Bioconjug Chem. 2002 Nov-Dec;13(6):1226-37. doi: 10.1021/bc025573a. Bioconjug Chem. 2002. PMID: 12440857

6

Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake.

Gammon ST, Villalobos VM, Prior JL, Sharma V, Piwnica-Worms D. Gammon ST, et al. Bioconjug Chem. 2003 Mar-Apr;14(2):368-76. doi: 10.1021/bc0256291. Bioconjug Chem. 2003. PMID: 12643747

7

Molecular imaging of protein-protein interactions: controlled expression of p53 and large T-antigen fusion proteins in vivo.

Luker GD, Sharma V, Pica CM, Prior JL, Li W, Piwnica-Worms D. Luker GD, et al. Cancer Res. 2003 Apr 15;63(8):1780-8. Cancer Res. 2003. PMID: 12702563

8

Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine.

Pichler A, Prior JL, Piwnica-Worms D. Pichler A, et al. Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1702-7. doi: 10.1073/pnas.0304326101. Epub 2004 Jan 30. Proc Natl Acad Sci U S A. 2004. PMID: 14755051 Free PMC article.

9

Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.

Rettig MP, Ritchey JK, Prior JL, Haug JS, Piwnica-Worms D, DiPersio JF. Rettig MP, et al. J Immunol. 2004 Sep 15;173(6):3620-30. doi: 10.4049/jimmunol.173.6.3620. J Immunol. 2004. PMID: 15356106

10

CXCR4 regulates growth of both primary and metastatic breast cancer.

Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD. Smith MC, et al. Cancer Res. 2004 Dec 1;64(23):8604-12. doi: 10.1158/0008-5472.CAN-04-1844. Cancer Res. 2004. PMID: 15574767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters